In other cancers, such as ovarian cancer, PCPE2 expression in tumor-associated macrophages was found to contribute to cancer progression along with enhanced ECM reorganization and elevated ascites levels of interleukins 6 and 10 (IL-6 and IL-10). This evidence concerns the gene IL6 and cancer.